The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view.
The major topics of the conference are:
• Epidemiology • Hemorrhages
• Thromboprophylaxis in Medical Patients • Anticoagulation and Cancer Survival
• Treatment of VTE • Arterial Thrombosis
• Thromboprophylaxis in Surgical Patients • New Antithrombotic drugs
• Bleeding Complications • Hypercoagulation and Biomarkers
• Congenital and Acquired Risk Factors • Gender- and Age-related Issues
• Thrombohemorrhagic Syndromes (e.g. DIC, TTP, NBTE) • Stem Cell Transplantation
• Hemostasis and Cancer biology • Antitumor Properties of Antithrombotics
• Molecular Mechanisms of Thrombosis in Cancer • Microparticles
• Tumor Cell/Vascular Cell Interactions • New Assays for Hypercoagulability
• Angiogenesis • Fibrinolysis
• Inflammation • Proteases